They discovered that when the level of PAPP-A is less than 25 MoM, it is linked to a range of maternal and fetal outcomes, including aneuploidy, non-proteinuric HDP, fetal growth restriction, and spontaneous abortion. The gene discussed is PAPPA; the disease is fetal growth restriction.